Literature DB >> 31497212

MiR-876-3p targets KIF20A to block JAK2/STAT3 pathway in glioma.

Jiao Tang1, Jie Xu2, Zhongwen Zhi3, Xiang Wang3, Yu Wang4, Yong Zhou3, Rui Chen3.   

Abstract

Aberrant expression of miRNAs has been reported to be involved in the development and progression of glioma. But the function of miR-876-3p in glioma is unknown. We found that miR-876-3p is significantly downregulated in glioma tissues and cell lines. Overexpression of miR-876-3p suppressed glioma cell proliferation, epithelial-mesenchymal transition, migration, and invasion. By prediction combining with luciferase reporter assay, we identified that miR-876-3p could decrease the expression of KIF20A by directly targeting the region of its 3'UTR. Furthermore, we observed that overexpression of miR-876-3p inhibited the expression of KIF20A, thus blocking the protein kinase JAK2/STAT3 pathway. Overexpressed KIF20A reversed miR-876-3p-induced suppression of glioma cell proliferation, migration, and invasion. We also demonstrated the inhibitory effect of miR-876-3p on tumor growth in glioma using an in vivo model. The miR-876-3p/KIF20A-axis mediated JAK2/STAT3 pathway have therapeutic potential in glioma treatment.

Entities:  

Keywords:  EMT; Glioma; KIF20A; miR-876-3p; proliferation

Year:  2019        PMID: 31497212      PMCID: PMC6731397     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  28 in total

1.  Functional analysis of KIF20A, a potential immunotherapeutic target for glioma.

Authors:  Katsuya Saito; Shigeki Ohta; Yutaka Kawakami; Kazunari Yoshida; Masahiro Toda
Journal:  J Neurooncol       Date:  2017-01-09       Impact factor: 4.130

2.  Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.

Authors:  Mingqin Lu; Xiaoying Huang; Yongping Chen; Yangyang Fu; Chaona Xu; Wei Xiang; Cheng Li; Shengguo Zhang; Chang Yu
Journal:  IUBMB Life       Date:  2018-03-02       Impact factor: 3.885

3.  Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.

Authors:  Daniela Stangel; Mert Erkan; Malte Buchholz; Thomas Gress; Christoph Michalski; Susanne Raulefs; Helmut Friess; Jörg Kleeff
Journal:  J Surg Res       Date:  2015-03-30       Impact factor: 2.192

4.  Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance.

Authors:  P Khongkow; A R Gomes; C Gong; E P S Man; J W-H Tsang; F Zhao; L J Monteiro; R C Coombes; R H Medema; U S Khoo; E W-F Lam
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

5.  CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways.

Authors:  Xuejiao Liu; Yulong Chong; Yiming Tu; Ning Liu; Chenglong Yue; Zhenglei Qi; Huize Liu; Yao Yao; Hongmei Liu; Shangfeng Gao; Mingshan Niu; Rutong Yu
Journal:  J Hematol Oncol       Date:  2016-10-12       Impact factor: 17.388

6.  Positive expression of KIF20A indicates poor prognosis of glioma patients.

Authors:  Jia Duan; Wei Huang; Haiping Shi
Journal:  Onco Targets Ther       Date:  2016-11-02       Impact factor: 4.147

7.  PI3K, p38 and JAK/STAT signalling in bronchial tissue from patients with asthma following allergen challenge.

Authors:  Thomas Southworth; Sarah Mason; Alan Bell; Isabel Ramis; Marta Calbet; Anna Domenech; Neus Prats; Montserrat Miralpeix; Dave Singh
Journal:  Biomark Res       Date:  2018-04-11

8.  KIF20A-mediated RNA granule transport system promotes the invasiveness of pancreatic cancer cells.

Authors:  Keisuke Taniuchi; Mutsuo Furihata; Toshiji Saibara
Journal:  Neoplasia       Date:  2014-12       Impact factor: 5.715

9.  Phase I/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancer.

Authors:  Shingo Asahara; Kazuyoshi Takeda; Kenji Yamao; Hiroyuki Maguchi; Hiroki Yamaue
Journal:  J Transl Med       Date:  2013-11-16       Impact factor: 5.531

10.  Aberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis.

Authors:  Chao Shi; Dengliang Huang; Nonghua Lu; Dan Chen; Minhong Zhang; Yehong Yan; Libin Deng; Quqin Lu; Hua Lu; Shiwen Luo
Journal:  Oncotarget       Date:  2016-05-03
View more
  9 in total

1.  Silencing LINC00504 inhibits cell proliferation, invasion as well as migration and promotes cell apoptosis in lung cancer cells via upregulating miR-876-3p.

Authors:  Zhen Zhang
Journal:  Cytotechnology       Date:  2020-10-08       Impact factor: 2.058

2.  Circ_0016760 Serves as a Cancer Promoter in Non-small Cell Lung Cancer Through miR-876-3p/NOVA2 Axis.

Authors:  Fengjie Liu; Haiying Gao; Mingwei Chen; Anqi Li; Ting Liu
Journal:  Biochem Genet       Date:  2022-03-03       Impact factor: 1.890

3.  Long Intergenic Non-Protein Coding RNA 519 Promotes the Biological Activities of Tongue Squamous Cell Carcinoma by Sponging microRNA-876-3p and Consequently Upregulating MACC1.

Authors:  Dejun Liu; Jing Zhao; Huiling Wang; Hui Li; Yanjie Li; Wangsen Qin
Journal:  Onco Targets Ther       Date:  2020-11-20       Impact factor: 4.147

4.  Dysregulation of SPRR3/miR-876-3p Axis Contributes to Tumorigenesis in Non-Small-Cell Lung Cancer.

Authors:  Qin Li; Yuxuan Wang; Rongkuan Hu; Guang Yang
Journal:  Onco Targets Ther       Date:  2020-03-23       Impact factor: 4.147

5.  A novel miR-7156-3p-HOXD13 axis modulates glioma progression by regulating tumor cell stemness.

Authors:  Junfeng Zhang; Mengsheng Deng; Haipeng Tong; Wei Xue; Yu Guo; Jianmin Wang; Lizhao Chen; Shunan Wang
Journal:  Int J Biol Sci       Date:  2020-10-21       Impact factor: 6.580

6.  LINC00504 Promotes the Malignant Biological Behavior of Breast Cancer Cells by Upregulating HMGB3 via Decoying MicroRNA-876-3p.

Authors:  Hao Yu; Liqian Dong; Hongyu Wang; Yang Zhang; Zhuo Wang; Can Wang; Hong Xia; Huizheng Bao
Journal:  Cancer Manag Res       Date:  2021-02-22       Impact factor: 3.989

7.  A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.

Authors:  Qianwei Xing; Tengyue Zeng; Shouyong Liu; Hong Cheng; Limin Ma; Yi Wang
Journal:  BMC Cancer       Date:  2021-04-09       Impact factor: 4.430

8.  Circ-RNF111 aggravates the malignancy of gastric cancer through miR-876-3p-dependent regulation of KLF12.

Authors:  Guoxian Wu; Aimin Zhang; Yinglin Yang; Dongping Wu
Journal:  World J Surg Oncol       Date:  2021-08-30       Impact factor: 2.754

Review 9.  Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition.

Authors:  Wook Jin
Journal:  Cells       Date:  2020-01-15       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.